Lupin announced that it has received final approval from the Food and Drug Administration (FDA) for Blisovi Fe 1/20 and Blisovi 1.5/30 (norethindrone acetate/ethinyl estradiol and ferrous fumarate) Tablets, the generic version of Warner Chilcott’s Loestrin Fe 1/20 and Loestrin Fe 1.5/30.
Loestrin Fe 1/20 and Loestrin Fe 1.5/30 are progestin and estrogen combination contraceptives indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Blisovi Fe 1/20 will be available as 1mg/0.02mg norethindrone acetate/ethinyl estradiol tablets with 75mg ferrous fumarate tablets. Blisovi 1.5/30 will be available as 1.5mg/0.03mg norethindrone acetate/ethinyl estradiol tablets with 75mg ferrous fumarate tablets.
For more information call (800) 399-2561 or visit Lupinpharmaceuticals.com.